A Comparison of the Effects of Three Different Estrogen Used for Endometrium Preparation on the Outcome of Day 5 Frozen Embryo Transfer Cycle

Overview

Journal JBRA Assist Reprod

Specialty Reproductive Medicine

Date 2020 Sep 29

PMID 32991118

Citations 2

Authors

Juliano Brum Scheffer

Bruno Brum Scheffer

Ana Paula de Souza Aguiar

Juliana Baumgratz Franca

Daniel Mendez Lozano

Renato Fanchin

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the effects of three different estrogen used for endometrium preparation on pregnancy rate, as well as hormone profile on day 5 frozen embryo transfer (FET) cycles.

Methods: Retrospective, observational study. Setting: A tertiary teaching and research private reproductive medicine center. Patients: Ninety patients who were undergoing endometrium preparation for day five frozen embryo transfer cycle (FET). Intervention(s): The women were divided in three groups according to the administration route of estrogen (E2): oral (Primogyna), transdermal patches (Estradot), or transdermal gel (Oestrogel Pump). These administration routines of estrogen are equivalent to 6mg of estradiol daily. All women received 600mg of vaginal progesterone (P) per day (Utrogestan) for luteal phase support. We drew blood samples on starting P day, as well as on beta hCG day for E2 and P measurements. Main Outcome Measure(s): Clinical pregnancy rates (PR).

Results: Patient features in the three groups were comparable. There were no significant differences concerning implantation rate, clinical PR, miscarriage rate, multiple-pregnancy rate, or E2 and P levels on starting P day and on beta hCG day.

Conclusions: In FET cycles with oral (Primogyna) or transdermal patches (Estradot), or transdermal gel (Oestrogel Pump), there was no significant difference on pregnancy rates.

Citing Articles

Short (seven days) versus standard (fourteen days) oestrogen administration in a programmed frozen embryo transfer cycle: a retrospective cohort study.

Jiang W, Song J, Sun Z J Ovarian Res. 2022; 15(1):36.

PMID: 35313944 PMC: 8939227. DOI: 10.1186/s13048-022-00967-5.

Duration of estradiol supplementation in luteal phase support for frozen embryo transfer in hormone replacement treatment cycles: a randomized, controlled phase III trial.

Ghaffari F, Chekini Z, Vesali S Arch Gynecol Obstet. 2021; 305(3):767-775.

PMID: 34561715 DOI: 10.1007/s00404-021-06173-w.

References

Berger B, Phillips J . Pregnancy outcomes in oocyte donation recipients: vaginal gel versus intramuscular injection progesterone replacement. J Assist Reprod Genet. 2012; 29(3):237-42. PMC: 3288138. DOI: 10.1007/s10815-011-9691-9. View

Wang A, Santistevan A, Hunter Cohn K, Copperman A, Nulsen J, Miller B . Freeze-only versus fresh embryo transfer in a multicenter matched cohort study: contribution of progesterone and maternal age to success rates. Fertil Steril. 2017; 108(2):254-261.e4. DOI: 10.1016/j.fertnstert.2017.05.007. View

Groenewoud E, Cantineau A, Kollen B, Macklon N, Cohlen B . What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update. 2013; 19(5):458-70. DOI: 10.1093/humupd/dmt030. View

van der Linden M, Buckingham K, Farquhar C, Kremer J, Metwally M . Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015; (7):CD009154. PMC: 6461197. DOI: 10.1002/14651858.CD009154.pub3. View

Hofmann G, THIE J, Scott Jr R, Navot D . Endometrial thickness is predictive of histologic endometrial maturation in women undergoing hormone replacement for ovum donation. Fertil Steril. 1996; 66(3):380-3. DOI: 10.1016/s0015-0282(16)58504-5. View

Kodaman P, Taylor H . Hormonal regulation of implantation. Obstet Gynecol Clin North Am. 2004; 31(4):745-66, ix. DOI: 10.1016/j.ogc.2004.08.008. View

Weissman A, Gotlieb L, Casper R . The detrimental effect of increased endometrial thickness on implantation and pregnancy rates and outcome in an in vitro fertilization program. Fertil Steril. 1999; 71(1):147-9. DOI: 10.1016/s0015-0282(98)00413-0. View

Schmidt C, De Ziegler D, Gagliardi C, Mellon R, Taney F, Kuhar M . Transfer of cryopreserved-thawed embryos: the natural cycle versus controlled preparation of the endometrium with gonadotropin-releasing hormone agonist and exogenous estradiol and progesterone (GEEP). Fertil Steril. 1989; 52(4):609-16. DOI: 10.1016/s0015-0282(16)60973-1. View

Propst A, Hill J, Ginsburg E, Hurwitz S, Politch J, Yanushpolsky E . A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles. Fertil Steril. 2001; 76(6):1144-9. DOI: 10.1016/s0015-0282(01)02872-2. View

10.

Chang E, Han J, Kim Y, Lyu S, Lee W, Yoon T . Use of the natural cycle and vitrification thawed blastocyst transfer results in better in-vitro fertilization outcomes : cycle regimens of vitrification thawed blastocyst transfer. J Assist Reprod Genet. 2011; 28(4):369-74. PMC: 3114968. DOI: 10.1007/s10815-010-9530-4. View

11.

Liu K, Hartman M, Hartman A, Luo Z, Mahutte N . The impact of a thin endometrial lining on fresh and frozen-thaw IVF outcomes: an analysis of over 40 000 embryo transfers. Hum Reprod. 2018; 33(10):1883-1888. PMC: 6145412. DOI: 10.1093/humrep/dey281. View

12.

Isaacs Jr J, WELLS C, Williams D, Odem R, Gast M, Strickler R . Endometrial thickness is a valid monitoring parameter in cycles of ovulation induction with menotropins alone. Fertil Steril. 1996; 65(2):262-6. DOI: 10.1016/s0015-0282(16)58082-0. View

13.

Kuwayama M, Vajta G, Kato O, Leibo S . Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online. 2005; 11(3):300-8. DOI: 10.1016/s1472-6483(10)60837-1. View

14.

Ghobara T, Gelbaya T, Ayeleke R . Cycle regimens for frozen-thawed embryo transfer. Cochrane Database Syst Rev. 2017; 7:CD003414. PMC: 6483463. DOI: 10.1002/14651858.CD003414.pub3. View

15.

Glujovsky D, Pesce R, Fiszbajn G, Sueldo C, Hart R, Ciapponi A . Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev. 2010; (1):CD006359. DOI: 10.1002/14651858.CD006359.pub2. View

16.

Ghobara T, Vandekerckhove P . Cycle regimens for frozen-thawed embryo transfer. Cochrane Database Syst Rev. 2008; (1):CD003414. DOI: 10.1002/14651858.CD003414.pub2. View

17.

Shapiro H, Cowell C, Casper R . The use of vaginal ultrasound for monitoring endometrial preparation in a donor oocyte program. Fertil Steril. 1993; 59(5):1055-8. DOI: 10.1016/s0015-0282(16)55927-5. View

18.

Shapiro D, Pappadakis J, Ellsworth N, Hait H, Nagy Z . Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts. Hum Reprod. 2014; 29(8):1706-11. PMC: 4093993. DOI: 10.1093/humrep/deu121. View

19.

Wu Y, Gao X, Lu X, Xi J, Jiang S, Sun Y . Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration. Reprod Biol Endocrinol. 2014; 12:96. PMC: 4197319. DOI: 10.1186/1477-7827-12-96. View

20.

Cicinelli E, De Ziegler D . Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus. Hum Reprod Update. 1999; 5(4):365-72. DOI: 10.1093/humupd/5.4.365. View